Mario Germano Giuliani

$1.94B

as of 04/02/25

About Mario Germano Giuliani

Mario Germano Giuliani is a healthcare investor who owns an 8% stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties.

Royalty Pharma went public in 2020 and has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica and Xtandi.

Mario and his brother Giammaria also own stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S.

The brothers share ownership of their family's pharmaceutical company, Giuliani, founded by their great-grandfather Germano in Milan, Italy in 1889.

They also own real estate investments in Europe and the U.S., including a planned commercial and residential project on a maritime platform in Monaco.

Personal stats

Citizenship

Switzerland

Source of wealth

Pharmaceuticals

Residence

Monaco, Monaco

Marital status

Married

Birth date

02/26/72 (age 53)

Education

Bachelor of Arts/Economics, Catholic University of the Sacred Heart

Self-made

inherited and growing